MAPT and Alzheimer disease: Compared to the saline-treated WT group, the saline-treated 3xTg-AD group exhibited a significant increase in total Tau protein (p = 0.007), which was unaffected by treatment with palm11-PrRP31, Dpr3-ghrelin, or liraglutide (Fig. 7.B).